Home › Funds › Frazier Life Sciences Management, L.P. › IBIO

Frazier Life Sciences Management, L.P. position in IBIO

IBIO INC · Health Care

Frazier Life Sciences Management, L.P. reported holding 1,953,467 shares of IBIO (IBIO INC) in its Q2 2026 13F filing — a position valued at US$3.4M, representing 0.07% of its reported portfolio and ranking #41 among its reported holdings. Frazier Life Sciences Management, L.P. has disclosed IBIO holdings in 3 of the last 3 reported quarters, going back to Q4 2025.

Latest position (Q2 2026)1.95M sh
Reported value held$3.42M
Portfolio Weight0.07%
First reportedQ4 2025
Last changeHold
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Frazier Life Sciences Management, L.P.'s IBIO position evolved

Frazier Life Sciences Management, L.P. first disclosed a stake in IBIO in Q4 2025 at 1,953,467 shares (US$3.8M). Across 3 filings, Frazier Life Sciences Management, L.P. held the position steady without any share-count change. The most recent filing (Q2 2026) shows 1,953,467 shares valued at US$3.4M.

Quarter by quarter

QuarterSharesValueChange
Q4 2025 1.95M $3.77M New
Q1 2026 1.95M $3.71M Hold
Q2 2026 1.95M $3.42M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About IBIO and 13F data

IBIO (IBIO INC) is a Health Care company. 44 other funds we track also report a position in IBIO — the largest reported positions include Cormorant Asset Management, LP (US$6.2M), SILVERARC CAPITAL MANAGEMENT, LLC (US$6.2M), Sio Capital Management, LLC (US$1.6M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding IBIO

All IBIO fund holders →

FAQ

How long has Frazier Life Sciences Management, L.P. held IBIO?

Frazier Life Sciences Management, L.P. has disclosed IBIO holdings in 3 of the last 3 reported quarters, going back to Q4 2025.

What is Frazier Life Sciences Management, L.P.'s current position in IBIO?

As of Q2 2026, Frazier Life Sciences Management, L.P. holds 1.95M shares of IBIO (IBIO INC), valued at $3.42M, representing 0.07% of its reported portfolio and ranking #41.

Has Frazier Life Sciences Management, L.P. been buying or selling IBIO?

In the latest 13F filing (Q2 2026), Frazier Life Sciences Management, L.P. held unchanged its position in IBIO.

Which other funds hold IBIO?

Other major institutional holders of IBIO include Cormorant Asset Management, LP, SILVERARC CAPITAL MANAGEMENT, LLC, Sio Capital Management, LLC, among 44 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.